PDUFA date pushed 3 months
Permanent treatment discontinuation rates due to TEAEs were very low with 0.7% (1 participant, 2 mg), 0.7% (1 participant, 4 mg), 1.4% (2 participants, 6 mg) and 0% (placebo)
Researchers outside of clinical trial settings rarely access this grade, but it represents the benchmark against which everything else should be measured
Ro Announces Research Collaboration to Better Understand and Improve the Real-World Patient Experience with GLP-1s ro.co To view or add a comment, sign in More Relevant Posts Aon's GLP-1 study brings additional data points to employers looking to make the best decisions specific to their people strategy and population
Wegovy (semaglutide) is FDA-approved specifically for chronic weight management in adults meeting certain criteria
Although more research is needed, emerging evidence suggests that well-formulated ketogenic diets may help prevent loss of muscle in people who are actively losing weight
